Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult ParticipantsCompleted
NCT05963984Phase 2Updated Dec 26, 2025
Sponsor: Carrick Therapeutics Limited
Metastatic Breast Cancer · Locally Advanced Breast Cancer · Breast Cancer
United States, Hungary, Mexico, Spain, Turkey (Türkiye)
A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy ParticipantsWithdrawn
NCT06397144Phase 1Updated Dec 26, 2025
Sponsor: Pfizer
Biological Availability · Healthy Participants
A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in FranceCompleted
NCT05838664N/AUpdated Dec 24, 2025
Sponsor: Pfizer
Atrial Fibrillation
France
Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the USRecruiting
NCT07301008Phase 4Updated Dec 24, 2025
Sponsor: Medstar Health Research Institute
Migraine · Trigger Induced Migraine
United States
To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.Completed
NCT05576051N/AUpdated Dec 23, 2025
Sponsor: Pfizer
Rheumatoid Arthritis
United States
Balancing Lupus Experiences With Stress StrategiesCompleted
NCT01351662Phase 1, Phase 2Updated Dec 22, 2025
Sponsor: Medical University of South Carolina
Systemic Lupus Erythematosus
United States
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young AdultsRecruiting
NCT07197762Phase 4Updated Dec 22, 2025
Sponsor: Emory University
Neisseria Meningitidis
United States
Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.Terminated
NCT05069259N/AUpdated Dec 19, 2025
Sponsor: Pfizer
Ulcerative Colitis
Switzerland
A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy ParticipantsCompleted
NCT07127770Phase 1Updated Dec 19, 2025
Sponsor: Pfizer
Healthy Adults
Netherlands
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac DiseaseCompleted
NCT06001177Phase 2Updated Dec 18, 2025
Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
Celiac Disease · Coeliac Disease
United States, Canada, Finland, Germany, Ireland +3 more
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseaseTerminated
NCT05348915Phase 3Updated Dec 17, 2025
Sponsor: Pfizer
Sickle Cell Disease · Vaso-occlusive Crisis · Vaso-occlusive Pain Episode in Sickle Cell Disease
United States, Brazil, Colombia, Kenya, Lebanon +5 more
Lorlatinib Continuation StudyActive Not Recruiting
NCT05144997Phase 4Updated Dec 17, 2025
Sponsor: Pfizer
Non-Small-Cell Lung Cancer · NSCLC
United States, China, France, India, Japan +3 more
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing RegimensCompleted
NCT05217927Phase 4Updated Dec 16, 2025
Sponsor: Pfizer
Migraine
United States, Austria, Canada, France, Germany +5 more
A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.Active Not Recruiting
NCT07284173Phase 1Updated Dec 16, 2025
Sponsor: Pfizer
Healthy Adults
China
A Study of SGN-B6A in Chinese Participants With Advanced Solid TumorsCompleted
NCT06549816Phase 1Updated Dec 15, 2025
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small Cell Lung · Squamous Cell Carcinoma of Head and Neck · Esophageal Squamous Cell Carcinoma · Gastric Adenocarcinoma
China
A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and TaiwanCompleted
NCT05512819Phase 3Updated Dec 15, 2025
Sponsor: Pfizer
Pneumococcal Disease
India, Taiwan
Measuring Outcomes With Validated ExerciseRecruiting
NCT07270185N/AUpdated Dec 12, 2025
Sponsor: Boston University
Physical Activity
United States
The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell AnemiaTerminated
NCT05018728Phase 2Updated Dec 12, 2025
Sponsor: Emory University
Sickle Cell Anemia in Children
United States
Description of Relugolix Use in Patients With Prostate Cancer Within the VHACompleted
NCT06462014N/AUpdated Dec 11, 2025
Sponsor: Pfizer
Prostate Cancer
United States
Monitoring Activity And Gait In ChildrenCompleted
NCT04823650N/AUpdated Dec 11, 2025
Sponsor: Pfizer
Child, Preschool · Child · Adolescent
United States
Epinephrine Dose: Optimal Versus Standard Evaluation TrialRecruiting
NCT03826524Phase 4Updated Dec 11, 2025
Sponsor: Unity Health Toronto
Cardiac Arrest, Out-Of-Hospital · Sudden Cardiac Arrest · Ventricular Fibrillation · Ventricular Tachycardia-Pulseless
Canada
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.Completed
NCT04671615N/AUpdated Dec 10, 2025
Sponsor: Pfizer
Metastatic Breast Cancer
Israel
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringRecruiting
NCT05721937N/AUpdated Dec 9, 2025
Sponsor: Pfizer
Atopic Dermatitis
United States
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerActive Not Recruiting
NCT01723774Phase 2Updated Dec 9, 2025
Sponsor: Washington University School of Medicine
Breast Neoplasms
United States
A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic DermatitisRecruiting
NCT05391061N/AUpdated Dec 9, 2025
Sponsor: Pfizer
Dermatitis, Atopic
South Korea

Previous page Next page